20 Years Focused on Artificial Intelligence (AI) Early Cancer Diagnostics
Landing Med’s vision is to decrease cancer-related mortalities around the world by detecting cancer in its earliest stages and extending screening services to underserved communities. Every time we diagnose a case, it’s more than just a test result. It’s a person. A life. A family. With this in mind, we strive for the very highest standards of quality control and apply them to every case.
Landing Med AI+Cloud diagnostic technologies are used by more than 1,300 hospitals across the world. Automation, intelligence, and standardization combine to make Landing Med’s products unique in its suitability for use in cancer screening programs for populations that lack qualified cytopathologists.